In this promotional presentation, the speaker introduces an AI‑augmented coronary CT angiography (CCTA) scan called ClearCardio™ that functions as a “living autopsy” of the heart. The AI overlay detects and quantifies coronary plaque far earlier than traditional stress tests or invasive catheterizations. It measures total plaque volume in cubic millimetres, distinguishes plaque type (soft vs. hard), assesses risk level, and stages disease from 0 (no plaque) to 3 (severe). The speaker highlights that 99 % of people have some plaque, and that one‑third of asymptomatic individuals with normal stress tests already have stage‑3 disease. By visualising the arterial wall (the “donut” itself) rather than just the blood‑flow lumen, the technology promises earlier intervention, plaque reversal, and a shift from reactive to preventive cardiology. The tone is persuasive and urgent, positioning ClearCardio™ as a breakthrough that makes old diagnostic tools obsolete.
Chapters
What if I told you we could do a living autopsy without ever touching a scalpel? That's what this scan, a CCTA with AI overlay, allows us to do. Not to just look at the heart, but into the blood vessels to see the exact plaque growing in your arteries years before it ever causes symptoms. We're not waiting for a blockage. We're not guessing based on cholesterol. We're looking directly at the wall of each coronary artery Where plaque always starts. And here's the game changer. Plaque doesn't grow in at first, it grows out. It can double the size of your artery wall without ever touching the flow of blood. That means your stress tests, it can look normal. Even if you're sitting on years of deadly unstable plaque, your eye can see about 50 shades of gray in these scans. Our AI sees 2,000. That's like turning on ultraviolet and infrared vision. We're not just seeing what's there, we're detecting what would be invisible by any other test. We measure total plaque volume in cubic millimeters. We break it down by vessel, plaque type— soft versus hard— risk level, and how much room it has left to grow before it becomes a danger. We stage it. 0, no plaque at all. Only 1% of people have no plaque whatsoever. 99% of us have either stage 1, mild, stage 2, moderate, or stage 3, severe. And here's what shocks most people. 1/3 of the people we scan who feel totally fine, who had a normal stress test last week, have stage 3 disease. That is the danger of waiting for symptoms. A heart catheterization can only see the donut hole where the blood flows. We see the donut itself, the vessel wall where the disease originates and lives. I stopped doing heart catheterizations 20 years ago because once you've seen this technology, you realize the old tools were Telescopes. This is a microscope. For decades, we only diagnosed heart disease when it was already late stage— blockage, stent, surgery, emergency. That's like diagnosing cancer at stage 4 and calling it a win. Now we can see stage 1 plaque. We can stop it. We can reverse it. That is the future of heart health, and the future is now.
